Néphrologie & Thérapeutique


Heart disease in hemodialysis: physiopathology and therapeutic breakthroughs Volume 19, issue 6, October 2023

1 Hôpitaux Sorbonne Université, sites Pitié-Salpêtrière, Tenon, AP-HP, service de néphrologie, Paris, France
2 Sorbonne Université, INSERM UMR_S 1155, Paris, France
3 Sorbonne Université, ACTION Study Group, INSERM UMRS 1166, Institut de cardiologie, Hôpital Pitié-Salpêtrière (AP-HP), Paris, France
Correspondance : L. Mercadal

Especially exposed to frequent cardiovascular events and its related mortality, some cardiovascular therapies of the hemodialyzed population as well as coronary investigations remain controversial. We have collected data and discussed recent trials and guidelines dedicated to this patient subset.